Author’s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Kioa Lente Wijnsma; Rob ter Heine; Jack F.M. Wetzels; Nicole C.A.J. van de Kar; Roger J. Brüggemann

doi:10.1007/s40262-020-00952-5

Author’s Reply to Liu et al. “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

Kioa Lente Wijnsma, Rob ter Heine, Jack F.M. Wetzels, Nicole C.A.J. van de Kar, Roger J. Brüggemann

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

Originele taal-2	Engels
Pagina's (van-tot)	1645-1646
Aantal pagina's	2
Tijdschrift	Clinical Pharmacokinetics
Volume	59
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1007/s40262-020-00952-5
Status	Gepubliceerd - dec. 2020
Extern gepubliceerd	Ja

Toegang tot document

10.1007/s40262-020-00952-5

Citeer dit

@article{28466b8a6a424e2ab985534a35904d90,

title = "Author{\textquoteright}s Reply to Liu et al.: “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”",

author = "Wijnsma, {Kioa Lente} and {ter Heine}, Rob and Wetzels, {Jack F.M.} and {van de Kar}, {Nicole C.A.J.} and Br{\"u}ggemann, {Roger J.}",

year = "2020",

month = dec,

doi = "10.1007/s40262-020-00952-5",

language = "English",

volume = "59",

pages = "1645--1646",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis International Ltd",

number = "12",

}

Author’s Reply to Liu et al. “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”. / Wijnsma, Kioa Lente; ter Heine, Rob; Wetzels, Jack F.M. et al.
In: Clinical Pharmacokinetics, Vol. 59, Nr. 12, 12.2020, blz. 1645-1646.

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

TY - JOUR

T1 - Author’s Reply to Liu et al.

T2 - “Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab”

AU - Wijnsma, Kioa Lente

AU - ter Heine, Rob

AU - Wetzels, Jack F.M.

AU - van de Kar, Nicole C.A.J.

AU - Brüggemann, Roger J.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85094112374&partnerID=8YFLogxK

U2 - 10.1007/s40262-020-00952-5

DO - 10.1007/s40262-020-00952-5

M3 - Letter

C2 - 33118148

AN - SCOPUS:85094112374

SN - 0312-5963

VL - 59

SP - 1645

EP - 1646

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 12

ER -